Atantares Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Series B
- Investors
-
18
Atantares General Information
Description
Developer of semiconductor-driven biotechnology designed to enable high-throughput molecular synthesis. The company's technology integrates CMOS and MEMS microelectrode arrays with microfluidics for electrochemical oligonucleotide synthesis, enabling biotechnology organizations to perform automated DNA synthesis, gene sequencing, primer synthesis, gene editing, and molecular screening at scale.
Contact Information
Website
www.atantares.comCorporate Office
- Room 902A, Building 4, Zhuangyan Liang'an Fenghui
- Number 236 Chuangyuan Road, Industrial Park
- Suzhou, Jiangsu 201800
- China
Corporate Office
- Room 902A, Building 4, Zhuangyan Liang'an Fenghui
- Number 236 Chuangyuan Road, Industrial Park
- Suzhou, Jiangsu 201800
- China
Atantares Timeline
Atantares Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series B) | 15-Sep-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A1) | 20-Jan-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 25-Jul-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 15-Jul-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 28-Feb-2023 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 04-May-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 19-Jul-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | 01-Jan-2020 | $50K | $50K | Completed | Generating Revenue | |
| 2. Grant | 17-Feb-2018 | $4.45M | Completed | Startup |
Atantares Comparisons
Industry
Financing
Details
Atantares Competitors (29)
One of Atantares’s 29 competitors is DNA Script, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DNA Script | Venture Capital-Backed | Paris, France | ||||
| Ansa Biotechnologies | Venture Capital-Backed | Emeryville, CA | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA | ||||
| Eurofins Genomics Blue Heron | Formerly VC-backed | Bothell, WA | ||||
| Genewiz | Formerly VC-backed | South Plainfield, NJ |
Atantares Patents
Atantares Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200055044-A1 | Methods and systems for micro platelet function testing using an integrated miniaturized platelet function analyzer | Inactive | 02-Nov-2016 | ||
| WO-2018085496-A2 | Methods and systems for micro platelet function testing using an integrated miniaturized platelet function analyzer | Inactive | 02-Nov-2016 | ||
| WO-2018085496-A3 | Methods and systems for micro platelet function testing using an integrated miniaturized platelet function analyzer | Inactive | 02-Nov-2016 | ||
| US-20180172663-A1 | A mems thrombelastograph/viscoelasticity analyzer | Inactive | 15-Jun-2015 | ||
| WO-2016205243-A1 | A mems thrombelastograph/viscoelasticity analyzer | Inactive | 15-Jun-2015 | G01N33/49 |
Atantares Signals
Atantares Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China Capital Management | PE/Buyout | Minority | ||
| Jiangsu Zhonggao Private Equity Fund Management | Government | Minority | ||
| Leader Venture Capital | Growth/Expansion | Minority | ||
| Aramco Ventures | Corporate Venture Capital | Minority | ||
| Suzhou Angel Fund of Funds | Government | Minority |
Atantares FAQs
-
When was Atantares founded?
Atantares was founded in 2017.
-
Where is Atantares headquartered?
Atantares is headquartered in Suzhou, China.
-
What is the size of Atantares?
Atantares has 60 total employees.
-
What industry is Atantares in?
Atantares’s primary industry is Biotechnology.
-
Is Atantares a private or public company?
Atantares is a Private company.
-
What is Atantares’s current revenue?
The current revenue for Atantares is .
-
How much funding has Atantares raised over time?
Atantares has raised $28.3M.
-
Who are Atantares’s investors?
China Capital Management, Jiangsu Zhonggao Private Equity Fund Management, Leader Venture Capital, Aramco Ventures, and Suzhou Angel Fund of Funds are 5 of 18 investors who have invested in Atantares.
-
Who are Atantares’s competitors?
DNA Script, Ansa Biotechnologies, Integrated DNA Technologies, Eurofins Genomics Blue Heron, and Genewiz are some of the 29 competitors of Atantares.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process